Oncolytics Biotech Inc(NASDAQ:ONCY) 
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies. Th...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.51
H 0.51
L 0.47
C 0.50
V 501,891
10EMA 0.50
20EMA 0.50
60EMA 0.50
120EMA 0.50
250EMA 0.50